Prevalence In a review of research articles on various aspects of<unk>  care, the prevalence of<unk>  was reported as highly varied. In<unk>  care units or hospice, the prevalence ranged from 3.1%-51%. In the home care setting, two Italian studies reported a prevalence of 25% and 52.5%. Hospital-based<unk>  support teams vary in prevalence, with reports of 1.33% and also 26%. Different countries also report large differences in prevalence of<unk> : + Country Prevalence Netherlands 10% Belgium 8.2% Italy 8.5% Denmark 2.5% Switzerland 4.8% Sweden 3% A 2009 survey of almost 4000 U.K. people whose care had followed the Liverpool Care Pathway for the Dying Patient found that while 31% had received low doses of medication to control distress from agitation or restlessness, only 4% had required higher doses. Almost half of the studies reviewed differentiated intermittent versus continuous<unk> . The prevalence of intermittent<unk>  was 30% -67% of cases and continuous<unk>  was 14-68% of cases. People starting intermittent<unk>  may progress to use of continuous<unk>  in 10 - 27% of cases. The prevalence of mild versus deep<unk>  was also reported: one study reported 51% of cases used mild<unk>  and 49% deep<unk> ; a second study reported 80% of cases used mild<unk>  and 20% deep<unk> . Survival There are reports that after initiation of<unk> , 38% of people died within 24 hours and 96% of people died within one week. Other studies report a survival time of 1 week for 27% of people. Another study reported people receiving<unk>  in their last week of life survived longer than those who did not receive<unk> , or only received<unk>  during last 48 hours of life. According to 2009 research, 16.5% of all deaths in the United Kingdom during 2007–2008 took place after continuous deep<unk> .
Palliative sedation
Alcohol detoxification
Stimulant maintenance
Physical restraint
Opioid tapering
Sedoanalgesia
Methadone maintenance
Psychedelic therapy